Loading…
Please register to continue your trial period!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Budenoside (specifically the multimatrix or MMX formulation) is approved by both the FDA and EMA for the induction of remission in patients with active, mild-to-moderate ulcerative colitis (UC) who are not adequately responsive to first-line therapy with 5-aminosalicylic acid (5-ASA/mesalazine).
…